Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A RUIZ TORRES

Showing results (51-60 of 59) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 59 results.
Medrxiv : the Preprint Server for Health Sciences|September 24, 2024
Immune Cell Densities Predict Response to Immune Checkpoint-Blockade in Head and Neck CancerDaniel A Ruiz-Torres, Michael E Bryan, Shun Hirayama, et al.
Frontiers in Immunology|December 19, 2024
Dendritic cell effector mechanisms and tumor immune microenvironment infiltration define TLR8 modulation and PD-1 blockadeDaniel A Ruiz-Torres, Jillian F Wise, Brian Yinge Zhao, et al.
Oncoimmunology|February 18, 2025
Spatial characterization of tertiary lymphoid structures as predictive biomarkers for immune checkpoint blockade in head and neck squamous cell carcinomaDaniel A Ruiz-Torres, Michael E Bryan, Shun Hirayama, et al.
Medrxiv : the Preprint Server for Health Sciences|February 20, 2025
Personalized circulating tumor DNA dynamics predict survival and response to immune checkpoint blockade in recurrent/metastatic head and neck cancerDaniel A Ruiz-Torres, Ross D Merkin, Michael Bryan, et al.
Medrxiv : the Preprint Server for Health Sciences|February 20, 2025
Immediate postoperative minimal residual disease detection with MAESTRO predicts recurrence and survival in head and neck cancer patients treated with surgeryEdward S Sim, Justin Rhoades, Kan Xiong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 20, 2025
Early Postoperative Minimal Residual Disease Detection with MAESTRO Is Associated with Recurrence and Worse Survival in Patients with Head and Neck CancerEdward S Sim, Justin Rhoades, Kan Xiong, et al.
NPJ Precision Oncology|August 22, 2025
Personalized circulating tumor DNA dynamics inform survival and response to immune checkpoint blockade in recurrent/metastatic head and neck cancerDaniel A Ruiz-Torres, Ross D Merkin, Michael E Bryan, et al.
Medrxiv : the Preprint Server for Health Sciences|February 6, 2026
Prognostic value of tumor-informed ctDNA in HPV-independent head and neck squamous cell carcinomaDaniel A Ruiz-Torres, Thomas J Roberts, Pan Du, et al.
JAMA Otolaryngology-- Head & Neck Surgery|January 22, 2026
Prognostic Value of Tumor-Informed Circulating Tumor DNA in HPV-Independent Head and Neck Squamous Cell CarcinomaDaniel A Ruiz-Torres, Thomas J Roberts, Pan Du, et al.
Pageof 6

Showing results (51-60 of 59) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
Medrxiv : the Preprint Server for Health Sciences|September 24, 2024
Immune Cell Densities Predict Response to Immune Checkpoint-Blockade in Head and Neck CancerDaniel A Ruiz-Torres, Michael E Bryan, Shun Hirayama, et al.
Frontiers in Immunology|December 19, 2024
Dendritic cell effector mechanisms and tumor immune microenvironment infiltration define TLR8 modulation and PD-1 blockadeDaniel A Ruiz-Torres, Jillian F Wise, Brian Yinge Zhao, et al.
Oncoimmunology|February 18, 2025
Spatial characterization of tertiary lymphoid structures as predictive biomarkers for immune checkpoint blockade in head and neck squamous cell carcinomaDaniel A Ruiz-Torres, Michael E Bryan, Shun Hirayama, et al.
Medrxiv : the Preprint Server for Health Sciences|February 20, 2025
Personalized circulating tumor DNA dynamics predict survival and response to immune checkpoint blockade in recurrent/metastatic head and neck cancerDaniel A Ruiz-Torres, Ross D Merkin, Michael Bryan, et al.
Medrxiv : the Preprint Server for Health Sciences|February 20, 2025
Immediate postoperative minimal residual disease detection with MAESTRO predicts recurrence and survival in head and neck cancer patients treated with surgeryEdward S Sim, Justin Rhoades, Kan Xiong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 20, 2025
Early Postoperative Minimal Residual Disease Detection with MAESTRO Is Associated with Recurrence and Worse Survival in Patients with Head and Neck CancerEdward S Sim, Justin Rhoades, Kan Xiong, et al.
NPJ Precision Oncology|August 22, 2025
Personalized circulating tumor DNA dynamics inform survival and response to immune checkpoint blockade in recurrent/metastatic head and neck cancerDaniel A Ruiz-Torres, Ross D Merkin, Michael E Bryan, et al.
Medrxiv : the Preprint Server for Health Sciences|February 6, 2026
Prognostic value of tumor-informed ctDNA in HPV-independent head and neck squamous cell carcinomaDaniel A Ruiz-Torres, Thomas J Roberts, Pan Du, et al.
JAMA Otolaryngology-- Head & Neck Surgery|January 22, 2026
Prognostic Value of Tumor-Informed Circulating Tumor DNA in HPV-Independent Head and Neck Squamous Cell CarcinomaDaniel A Ruiz-Torres, Thomas J Roberts, Pan Du, et al.
Pageof 6